Our data showing that hornerin alters tumor perfusion and blood oxygen saturation suggest that it may be involved mechanistically at several regulatory nodes that govern tumor oxygen status, a feature that is currently being investigated in our lab. The gene discussed is HRNR; the disease is neoplasm.